[1]
M. Camargo, M. I. Soto Marín, O. Zea, and D. Saavedra, “Imatinib treatment and pharmacogenotype CYP3A4 in relation with the clonal expansion Ph(+) in chronic myeloid leukemia (CML).”, cm, vol. 39, no. 4, pp. 314-322, 1.